{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:35:39Z","timestamp":1780673739473,"version":"3.54.1"},"reference-count":50,"publisher":"SAGE Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["THC"],"published-print":{"date-parts":[[2024,11,8]]},"abstract":"<jats:p>BACKGROUND: Bone morphogenetic proteins (BMPs) are a group of cancer-related proteins vital for development and progression of certain cancer types. Nevertheless, function of BMP family in pan-cancer was not detailedly researched. OBJECTIVE: Investigating expression pattern and prognostic value of the BMPs family (BMP1-8A and BMP8B) expression across multiple cancer types. METHODS: Our research integrated multi-omics data for exploring potential associations between BMPs expression and prognosis, clinicopathological characteristics, copy number or somatic mutations, immune characteristics, tumor microenvironment (TME), tumor mutation burden (TMB), microsatellite instability (MSI), immune checkpoint genes and drug sensitivity in The Cancer Genome Atlas (TCGA) tumors. Furthermore, association of BMPs expression and immunotherapy effectiveness was investigated in some confirmatory cohorts (GSE111636, GSE78220, GSE67501, GSE176307, IMvigor210 and mRNA sequencing data from currently undergoing TRUCE01 clinical research included), and biological function and potential signaling pathways of BMPs in bladder cancer (BCa) was explored via Gene Set Enrichment Analysis (GSEA). Eventually, immune infiltration analysis was done via BMPs expression, copy number or somatic mutations in BCa, as well as validation of the expression levels by reverse transcription-quantitative PCR and western blot, and in vitro functional experiments of BMP8A. RESULTS: Discoveries displayed BMPs expression was related to prognosis, clinicopathological characteristics, mutations, TME, TMB, MSI and immune checkpoint genes of TCGA tumors. Anticancer drug sensitivity analysis displayed BMPs were associated with various drug sensitivities. What\u2019s more, it was discovered that expression level of certain BMP family members related to objective response to immunotherapy. By GSEA, we discovered multiple immune-associated functions and pathways were enriched. Immune infiltration analysis on BCa also displayed significant associations among BMPs copy number variations, mutation status and infiltration level of diverse immune cells. Furthermore, differential expression validation and in vitro phenotypic experiment indicated that BMP8A significantly promoted BCa cell proliferation, migration and invasion. CONCLUSIONS: Current results confirmed significance of both BMPs expression and genomic alteration in the prognosis and treatment of diverse cancer types, and suggested that BMPs may be vital for BCa and can possibly be utilized as biomarkers for immunotherapy.<\/jats:p>","DOI":"10.3233\/thc-232004","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T11:57:55Z","timestamp":1721390275000},"page":"4123-4175","source":"Crossref","is-referenced-by-count":2,"title":["The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysis"],"prefix":"10.1177","volume":"32","author":[{"given":"Changsheng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Department of Urology, Tianjin Haihe Hospital, Tianjin, China"},{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Department of Urology, The Eco-City Hospital of Tianjin Fifth Central Hospital, Tianjin, China"},{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuda","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouliang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkai","family":"Qie","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangjian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"},{"name":"Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/THC-232004_ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.3233\/THC-232004_ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030280"},{"issue":"12","key":"10.3233\/THC-232004_ref3","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/annonc\/mdu478","article-title":"Prioritizing targets for precision cancer medicine","volume":"25","author":"Andre","year":"2014","journal-title":"Ann Oncol."},{"key":"10.3233\/THC-232004_ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1969-6"},{"key":"10.3233\/THC-232004_ref5","doi-asserted-by":"publisher","first-page":"723817","DOI":"10.3389\/fcell.2021.723817","article-title":"Identification of immune-related subtypes and characterization of tumor microenvironment infiltration in bladder cancer","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"6","key":"10.3233\/THC-232004_ref6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.21037\/hbsn.2020.03.04","article-title":"Promising anticancer therapy: Combination of immune checkpoint inhibitors and molecular-targeted agents","volume":"9","author":"Sakurai","year":"2020","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"5","key":"10.3233\/THC-232004_ref7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrclinonc.2018.27","article-title":"Immunotherapy: Cancer immunotherapy and the value of cure","volume":"15","author":"Del Paggio","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"key":"10.3233\/THC-232004_ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129854"},{"issue":"5","key":"10.3233\/THC-232004_ref9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4111\/icu.2018.59.5.285","article-title":"Immune checkpoint inhibitors for urothelial carcinoma","volume":"59","author":"Kim","year":"2018","journal-title":"Investig Clin Urol."},{"issue":"5","key":"10.3233\/THC-232004_ref10","doi-asserted-by":"publisher","first-page":"e12530","DOI":"10.1111\/hel.12530","article-title":"Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data","volume":"23","author":"Hu","year":"2018","journal-title":"Helicobacter."},{"key":"10.3233\/THC-232004_ref11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.csbj.2019.12.014","article-title":"Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer","volume":"18","author":"Sun","year":"2020","journal-title":"Comput Struct Biotechnol J."},{"key":"10.3233\/THC-232004_ref12","doi-asserted-by":"publisher","first-page":"6663990","DOI":"10.1155\/2021\/6663990","article-title":"Abnormal expression and prognostic significance of bone morphogenetic proteins and their receptors in lung adenocarcinoma","volume":"2021","author":"Xu","year":"2021","journal-title":"Biomed Res Int."},{"key":"10.3233\/THC-232004_ref13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fonc.2020.00357","article-title":"Loss of Myeloid BMPR1a alters differentiation and reduces mouse prostate cancer growth","volume":"10","author":"Ihle","year":"2020","journal-title":"Front Oncol."},{"key":"10.3233\/THC-232004_ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omto.2017.10.002","article-title":"The dual role of bone morphogenetic proteins in cancer","volume":"8","author":"Bach","year":"2018","journal-title":"Mol Ther Oncolytics."},{"issue":"6","key":"10.3233\/THC-232004_ref15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol."},{"issue":"5","key":"10.3233\/THC-232004_ref16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"10.3233\/THC-232004_ref17","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal."},{"issue":"2","key":"10.3233\/THC-232004_ref18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell."},{"issue":"15","key":"10.3233\/THC-232004_ref19","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-17-3509","article-title":"A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations","volume":"24","author":"Tamborero","year":"2018","journal-title":"Clin Cancer Res."},{"issue":"24","key":"10.3233\/THC-232004_ref20","doi-asserted-by":"publisher","first-page":"13739","DOI":"10.1073\/pnas.241508898","article-title":"Bone morphogenetic protein 4 in the extraembryonic mesoderm is required for allantois development and the localization and survival of primordial germ cells in the mouse","volume":"98","author":"Fujiwara","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.3233\/THC-232004_ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031475"},{"issue":"1","key":"10.3233\/THC-232004_ref22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2022.0491","article-title":"Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment","volume":"20","author":"Zhu","year":"2023","journal-title":"Cancer Biol Med."},{"issue":"12","key":"10.3233\/THC-232004_ref23","doi-asserted-by":"publisher","first-page":"9475","DOI":"10.1007\/s13277-015-3681-y","article-title":"BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation","volume":"36","author":"Kim","year":"2015","journal-title":"Tumour Biol."},{"issue":"2","key":"10.3233\/THC-232004_ref24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3892\/ol.2019.11218","article-title":"Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer","volume":"19","author":"Hudolin","year":"2020","journal-title":"Oncol Lett."},{"key":"10.3233\/THC-232004_ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105123"},{"key":"10.3233\/THC-232004_ref26","doi-asserted-by":"publisher","first-page":"e920943","DOI":"10.12659\/MSM.920943","article-title":"Multi-omics analysis reveals the pan-cancer landscape of bone morphogenetic proteins","volume":"26","author":"Luo","year":"2020","journal-title":"Med Sci Monit."},{"issue":"2","key":"10.3233\/THC-232004_ref27","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1677\/ERC-09-0273","article-title":"Bone morphogenetic proteins in breast cancer: Dual role in tumourigenesis","volume":"17","author":"Alarmo","year":"2010","journal-title":"Endocr Relat Cancer."},{"issue":"15","key":"10.3233\/THC-232004_ref28","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.yexcr.2011.06.001","article-title":"Bone morphogenetic protein-4 and -5 in pancreatic cancer-novel bidirectional players","volume":"317","author":"Virtanen","year":"2011","journal-title":"Exp Cell Res."},{"key":"10.3233\/THC-232004_ref29","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8020019"},{"issue":"5","key":"10.3233\/THC-232004_ref30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41417-019-0107-9","article-title":"Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma","volume":"27","author":"Xiao","year":"2020","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.3233\/THC-232004_ref31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.18632\/oncotarget.6128","article-title":"Oncogenomic portals for the visualization and analysis of genome-wide cancer data","volume":"7","author":"Klonowska","year":"2016","journal-title":"Oncotarget."},{"issue":"7","key":"10.3233\/THC-232004_ref32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/2326-6066.CIR-15-0274","article-title":"Molecular drivers of the non-t-cell-inflamed tumor microenvironment in urothelial bladder cancer","volume":"4","author":"Sweis","year":"2016","journal-title":"Cancer Immunol Res."},{"issue":"9","key":"10.3233\/THC-232004_ref33","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S1470-2045(20)30234-5","article-title":"Turning up the heat on non-immunoreactive tumours: Opportunities for clinical development","volume":"21","author":"Ochoa de Olza","year":"2020","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.3233\/THC-232004_ref34","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med."},{"issue":"1","key":"10.3233\/THC-232004_ref35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","article-title":"Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: A systematic review","volume":"18","author":"Peltanova","year":"2019","journal-title":"Mol Cancer."},{"issue":"1","key":"10.3233\/THC-232004_ref36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun Signal."},{"issue":"7","key":"10.3233\/THC-232004_ref37","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/jmcb\/mjz071","article-title":"Mutant p53-a potential player in shaping the tumor-stroma crosstalk","volume":"11","author":"Stein","year":"2019","journal-title":"J Mol Cell Biol."},{"issue":"5","key":"10.3233\/THC-232004_ref38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell."},{"issue":"4","key":"10.3233\/THC-232004_ref39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/2211-5463.13111","article-title":"Analysis of the role of Frizzled 2 in different cancer types","volume":"11","author":"Zhou","year":"2021","journal-title":"FEBS Open Bio."},{"issue":"6","key":"10.3233\/THC-232004_ref40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.21037\/tlcr.2018.08.14","article-title":"Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians","volume":"7","author":"Allgauer","year":"2018","journal-title":"Transl Lung Cancer Res."},{"issue":"1","key":"10.3233\/THC-232004_ref41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann Oncol."},{"issue":"3","key":"10.3233\/THC-232004_ref42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bcmd.2006.10.163","article-title":"Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis-evidence for in vivo oxidation and lipid rafts protein variations","volume":"38","author":"Margetis","year":"2007","journal-title":"Blood Cells Mol Dis."},{"issue":"23","key":"10.3233\/THC-232004_ref43","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andre","year":"2020","journal-title":"N Engl J Med."},{"issue":"1","key":"10.3233\/THC-232004_ref44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/cas.14681","article-title":"Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma","volume":"112","author":"Ye","year":"2021","journal-title":"Cancer Sci."},{"key":"10.3233\/THC-232004_ref45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225724"},{"issue":"6","key":"10.3233\/THC-232004_ref46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc.2017.18","article-title":"The calcium-cancer signalling nexus","volume":"17","author":"Monteith","year":"2017","journal-title":"Nat Rev Cancer."},{"issue":"7","key":"10.3233\/THC-232004_ref47","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.4049\/jimmunol.1402691","article-title":"Canonical wnt signaling in dendritic cells regulates Th1\/Th17 responses and suppresses autoimmune neuroinflammation","volume":"194","author":"Suryawanshi","year":"2015","journal-title":"J Immunol."},{"issue":"7693","key":"10.3233\/THC-232004_ref48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature."},{"key":"10.3233\/THC-232004_ref49","doi-asserted-by":"publisher","first-page":"4273943","DOI":"10.1155\/2016\/4273943","article-title":"The immune system in cancer pathogenesis: Potential therapeutic approaches","volume":"2016","author":"Pandya","year":"2016","journal-title":"J Immunol Res."},{"issue":"6","key":"10.3233\/THC-232004_ref50","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J Clin Oncol."}],"container-title":["Technology and Health Care"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/THC-232004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:00:01Z","timestamp":1777615201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/THC-232004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":50,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3233\/thc-232004","relation":{},"ISSN":["0928-7329","1878-7401"],"issn-type":[{"value":"0928-7329","type":"print"},{"value":"1878-7401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}